Inverse Psoriasis

Case Presentation and Review

Abstract

Inverse psoriasis is a rare form of psoriasis that affects between 3% and 7% of psoriasis patients. Its appearance and distribution in the flexural skin folds makes it a difficult disease to diagnose, and because it is thought of as a variant of psoriasis, there are very few studies that deal with it exclusively. We present a short case report of inverse psoriasis and a review of the literature on various facets of this disease: epidemiology, histology, clinical presentation, differential diagnosis, and treatment.

This is a preview of subscription content, access via your institution.

Fig. 1

References

  1. 1.

    Wang G, Li C, Gao T, et al. Clinical analysis of 48 cases of inverse psoriasis: a hospital-based study. Eur J Dermatol 2005; 15 (3): 176–8

    PubMed  Google Scholar 

  2. 2.

    Kundacki N, Tursen U, Babikar MOA, et al. The evaluation of the sociodemographic and clinical features of Turkish psoriasis patients. Int J Dermatol 2002; 41: 220–4

    Article  Google Scholar 

  3. 3.

    van de Kerkhof PCM, Murphy GM, Austad J, et al. Psoriasis of the face and flexures. J Dermatolog Treat 2007; 18: 351–60

    PubMed  Article  Google Scholar 

  4. 4.

    Gelfand JM, Stern RS, Nijsten T, et al. The prevalence of psoriasis in African Americans: results from a population-based study. J Am Acad Dermatol 2005; 52 (1): 23–6

    PubMed  Article  Google Scholar 

  5. 5.

    Gudjonsson JE, Elder JT. Psoriasis: epidemiology. Clin Dermatol 2007; 25 (6): 535–46

    PubMed  Article  Google Scholar 

  6. 6.

    Fransson J, Storgards K, Hammar H. Palmoplantar lesions in psoriasis patients and their relation to inverse psoriasis, tinea infections and contact allergy. Acta Derm Venereol 1985; 65 (3): 218–23

    PubMed  CAS  Google Scholar 

  7. 7.

    Habif TP. Psoriasis and other papulosquamous diseases. In: Habif TP. Clinical dermatology. 4th ed. Edinburgh: Mosby, Inc., 2004: 209–66

    Google Scholar 

  8. 8.

    De Rosa G, Mignogna C. The histopathology of psoriasis. Reumatismo 2007; 59 Suppl. 1: 46–8

    PubMed  Google Scholar 

  9. 9.

    Ghoreschi K, Weigert C, Rocken M. Immunopathogenesis and role of T cells in psoriasis. Clin Dermatol 2007; 25 (6): 574–80

    PubMed  Article  Google Scholar 

  10. 10.

    Vissers WH, Roelofzen J, De Jong EM, et al. Flexural versus plaque lesions in psoriasis: an immunohistochemical differention. Eur J Dermatol 2005; 15 (1): 13–7

    PubMed  CAS  Google Scholar 

  11. 11.

    Peramiquel L, Puig L, Dalmau J, et al. Onset of flexural psoriasis during infliximab treatment for Crohn’s disease. ClinExp Dermatol 2005 Nov; 30: 707–26

    Google Scholar 

  12. 12.

    Pauluzzi P, Boccucci N. Inverse psoriasis induced by terbinafine [letter]. Acta Derm Venereol 1999 Sep; 79 (5): 389

    Google Scholar 

  13. 13.

    Shelley ED, Shelley WB. Inframammary, intertriginous, and decubital erosions due to etretinate. Cutis 1990 Feb; 45 (2): 111–3

    Google Scholar 

  14. 14.

    Hassan AS, Simon D, Simon H, et al. Efalizumab-associated papular psoriasis. Arch Dermatol 2007 Jul; 143 (7): 900–6

  15. 15.

    Rallis E, Koumantak-Mathioudaki E. Pimecrolimus induced tinea incognito masquerading as intertriginous psoriasis. Mycoses 2008 Jan; 51 (1): 71–3

  16. 16.

    Janniger CK, Schwartz RA, Szepietowski JC, et al. Intertrigo and common secondary skin infections. Am Fam Physician 2005 Sep; 72 (5): 833–8

  17. 17.

    Flystrom I, Bergbrant I, Brared J, et al. Microorganisms in intertriginous psoriasis: no evidence of Candida. Acta Derm Venereol 2003; 83 (2): 121–3

    Article  Google Scholar 

  18. 18.

    Leibovici V, Alkalay R, Hershko K, et al. Prevalence of Candida on the tongue and intertriginous areas of psoriatic and atopic dermatitis patients. Mycoses 2008 Jan; 51 (1): 63–6

    Google Scholar 

  19. 19.

    Lisi P. Differential diagnosis of psoriasis. Reumatismo 2007; 59 Suppl. 1: 56–60

    PubMed  Google Scholar 

  20. 20.

    Cheng S, Edmonds E, Ben-Gashir M, et al. Subcorneal pustular dermatosis: 50 years on. Clin Exp Dermatol 2008 May; 33 (3): 229–33

    Google Scholar 

  21. 21.

    Breier-Maly J, Ortel B, Breier F, et al. Generalized pustular psoriasis of pregnancy (impetigo herpetiformis). Dermatology 1999; 198 (1): 61–4

    PubMed  Article  CAS  Google Scholar 

  22. 22.

    Lebwohl MG, Tan M, Meador SL, et al. Limited application of fluticasone propionate ointment, 0.0005% in patients with psoriasis of the face and intertriginous areas. J Am Acad Dermatol 2001 Jan; 44 (1): 77–82

    Google Scholar 

  23. 23.

    Gribetz C, Ling M, Lebwohl M, et al. Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind randomized study. J Am Acad Dermatol 2004 Nov; 51 (5): 731–8

    Google Scholar 

  24. 24.

    Steele JA, Choi C, Kwong PC. Topical tacrolimus in the treatment of inverse psoriasis in children. J Am Acad Dermatol 2005 Oct; 53 (4): 713–6

  25. 25.

    Brune A, Miller DW, Lin P, et al. Tacrolimus ointment is effective for psoriasis on the face and intertriginous areas in pediatric patients. Pediatr Dermatol 2007; 24 (1): 76–80

    PubMed  Article  Google Scholar 

  26. 26.

    Ortonne JP, Humbert P, Nicolas JF, et al. Intra-individual comparison of the cutaneous safety and efficacy of calcitriol 3 mg/g ointment and calcipotriol 50 mg/g ointment on chronic plaque psoriasis localized in facial, hairline, retroauricular or flexural areas. Br J Dermatol 2003; 148: 326–33

    PubMed  Article  CAS  Google Scholar 

  27. 27.

    Lebwohl M, Ali S. Treatment of psoriasis: part 2. Systemic therapies. J Am Acad Dermatol 2001; 45 (5): 649–61

    PubMed  Article  CAS  Google Scholar 

  28. 28.

    Khachemoune A, Guillen S. Psoriasis: disease management with a brief review of new biologics. Dermatol Nurs 2006; 18 (1): 40–9

    PubMed  Google Scholar 

  29. 29.

    George D, Rosen T. Treatment of inverse psoriasis with efalizumab. J Drugs Dermatol 2009; 8 (1): 74–6

    PubMed  Google Scholar 

  30. 30.

    Kuehn B. Efalizumab withdrawn. JAMA 2009; 301 (20): 2085

    CAS  Google Scholar 

  31. 31.

    Lebwohl M, Ali S. Treatment of psoriasis: part 1. Topical therapy and phototherapy. J Am Acad Dermatol 2001; 45 (1): 487–98

    PubMed  Article  CAS  Google Scholar 

  32. 32.

    Mafong E, Friedman PM, Kauvar ANB, et al. Treatment of inverse psoriasis with the 308nm excimer laser. Dermatol Surg 2002; 28 (6): 530–2

    PubMed  Article  Google Scholar 

  33. 33.

    Carrascosa JM, Soria X, Domingo H, et al. Treatment of inverse psoriasis with excimer therapy and tacrolimus ointment. Dermatol Surg 2007; 33: 361–3

    PubMed  Article  CAS  Google Scholar 

  34. 34.

    Zanchi M, Favot F, Bizzarini M, et al. Botulinum toxin type-A for the treatment of inverse psoriasis. J Eur Acad Dermatol Venereol 2008; 22: 431–6

    PubMed  Article  CAS  Google Scholar 

  35. 35.

    Kalb RE, Bagel J, Korman NJ, et al. Treatment of intertriginous psoriasis: from the medical board of the National Psoriasis Foundation. J Am Acad Dermatol 2009 Jan; 60 (1): 120–4

    Google Scholar 

Download references

Acknowledgments

Zain U. Syed, MD, is currently a clinical research fellow at the Department of Dermatology, Henry Ford Medical Center in Detroit, MI, USA. Dr Khachemoune is a Mohs micrographic surgeon and a dermatopathologist at the Veterans Affairs Medical Center and the Department of Dermatology at the State University of New York in Brooklyn, NY, USA. Neither author has any conflicts of interest, sources of financial support, patent filings, or corporate involvement with respect to this case report.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Amor Khachemoune.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Syed, Z.U., Khachemoune, A. Inverse Psoriasis. Am J Clin Dermatol 12, 143–146 (2011). https://doi.org/10.2165/11532060-000000000-00000

Download citation

Keywords

  • Psoriasis
  • Tacrolimus
  • Psoriasis Patient
  • Pimecrolimus
  • Calcipotriol